4th annual
LIFE SCIENCES FORUM 2019
September 18
Convene 810 Seventh Ave, New York
Managing IP returned to New York on December 18 in 2019,
marking the Life Sciences Forum's 4th anniversary.
Managing IP hosted the fourth annual MIP Life Sciences Forum 2019 at the Convene 810 Seventh Ave, New York on September 18. The one day forum addressed the latest decisions and tumultuous changes affecting the life sciences industry.
AbbVie Inc. and Boehringer Ingelheim GmbH may have settled their biosimilar dispute in relation to Humira, the FDA's recent approval of Samsung Bioepis's biosimilar was at the same time followed by the almost immediate launch of litigation by Amgen in response
The two cases represent how difficult and complex the current landscape for patent prosecution and litigation is right now in the biosimilars markets and beyond. While the threats are huge, the opportunities have never been greater for those get their patent prosecution, protection, litigation, and commercialization strategies right.
Attendees were able to benchmark practices against those of peers and understand what was needed to take advantage of the considerable opportunities available, while at the same time protecting patents and minimising risk
Key discussions and themes for 2019
NETWORKING OPPORTUNITY >
Interactive roundtable discussions
designed to enhance the level of collaborative,
strategic discussion
50+ LIFE SCIENCES IP COUNSEL >
Share best practice and drawing on
the experience of your peers through
practical case studies with
legal perspectives and solutions
EXCLUSIVE INSIGHTS >
Industry masterclasses,
providing in-depth insight on key issues
Conference highlights
What do our attendees think?
"Information was clearly presented, updates on the law and patent practice tips"
"Great panel chemistry and venue, interesting subject matter"
"Made for an intimate environment for high level networking"
Sponsors
Sponsors
Sponsors
